2'-5'-oligoadenylate trimer has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpten, JD; Casey, G; Isaacs, WB; Klein, EA; Murakami, J; Plummer, S; Silverman, RH; Trent, JM; Wang, Z; Xiang, Y | 1 |
| Barna, BP; Koga, S; Komata, T; Kondo, S; Kondo, Y; Mukai, S | 1 |
2 other study(ies) available for 2'-5'-oligoadenylate trimer and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Topics: Adenine Nucleotides; Apoptosis; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; Dimerization; Endoribonucleases; Enzyme Activation; Humans; Lymphatic Metastasis; Male; Mutation, Missense; Oligoribonucleotides; Prostatic Neoplasms | 2003 |
2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Topics: Adenine Nucleotides; Animals; Brain Neoplasms; Cation Exchange Resins; Cations; Female; Glioma; Humans; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligoribonucleotides; Oligoribonucleotides, Antisense; RNA, Neoplasm; Telomerase; Tumor Cells, Cultured | 2000 |